Alphatec Holdings (ATEC) Appoints Marie Meynadier, PhD to its Board
Get Alerts ATEC Hot Sheet
Join SI Premium – FREE
Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today that Marie Meynadier, Ph.D., founder of EOS imaging, has been appointed as an independent director to the ATEC Board.
With over 25 years of experience in the high tech and medical device industries, Dr. Meynadier currently sits on boards of multiple medical technology companies in Europe and North America. She founded and served as Chief Executive Officer of EOS imaging until 2018, after which she remains a director and head of the Strategic Committee. Prior to her tenure at EOS, Dr. Meynadier served as Chief Executive Officer of Biospace Lab, a French preclinical imaging company, which she rapidly guided to profitability. She began her career in the semiconductor industry at Bellcore and ATT Bell Labs in New Jersey. Dr. Meynadier received a degree in electrical engineering from Sup Télécom, Paris, and her Ph.D. in physics from Ecole Normale Supérieure Ulm, Paris.
“We would like to welcome Marie to the ATEC team,” said Pat Miles, Chairman and Chief Executive Officer. “Her wealth of imaging expertise will be invaluable as we integrate EOS imaging and extend the technology to establish new standards in spine. We also look forward to leveraging Marie’s global leadership experience as we further develop and then execute ATEC’s strategy to expand into untapped international markets.”
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Rocket Companies adds Sarah Watterson to its board of directors
- Galmed's Aramchol shows added cell death in prostate cancer study
- Bitmine reports 5.82 million ETH holdings, $11.4B total assets
Create E-mail Alert Related Categories
Board Changes, Corporate NewsRelated Entities
Definitive AgreementSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share